『2 Minutes with Joey - VKTX Stock News』のカバーアート

2 Minutes with Joey - VKTX Stock News

2 Minutes with Joey - VKTX Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Viking Therapeutics (VKTX) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • VKTX Today - Aug 13: Obesity Pipeline Buzz

    VKTX Today - Aug 13: Obesity Pipeline Buzz
    2026/08/13
    Hey there! It’s Joey, your friendly neighborhood investor, and I’m here to break down what went down with Viking Therapeutics today. Spoiler alert: it was a red day for VKTX, dropping about 2.6%.

    So, here’s the scoop. VKTX started off the day looking pretty solid but then hit a bit of a wall. By the time the market closed, it was down almost a buck. Just a rough ride overall, you know?

    Now, why the dip? Well, there’s a mix of vibes going on. On one hand, there was some buzz about their obesity pipeline. People were feeling optimistic, thinking that could lead to good things. But then, bam! JPMorgan dropped a not-so-great forecast for the stock, which definitely made folks a bit skittish. It’s like one step forward, two steps back, right? And, just to throw a little more spice into the mix, they’ve been expanding their at-the-market offerings, which can sometimes make investors raise an eyebrow. So yeah, a lot of back and forth today.

    Looking ahead, it’s worth knowing that JPMorgan still has a price target of $65 on VKTX, even after lowering it. So, there’s still some belief in the long-term potential here, despite today’s hiccup.

    Alright, that’s the rundown on VKTX for today. Just remember, I'm here to keep you in the loop, not to dish out any financial advice. So, keep it chill and happy investing, friends!
    続きを読む 一部表示
    1 分
  • VKTX Today - Aug 12: Earnings Buzz in the Air

    VKTX Today - Aug 12: Earnings Buzz in the Air
    2026/08/12
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the day for you. Today, we’re chatting about Viking Therapeutics, or VKTX, and it was a bit of a green day, up about 1.2%.

    So, what went down? VKTX had some solid movement today, catching a little more attention than usual. The stock was riding high after news about expanding their at-the-market offerings and a new shelf registration. Investors seemed to like that. It’s like when you find out your favorite artist is dropping a surprise album – excitement in the air, you know?

    But, here’s the kicker. Despite the good vibes today, there were some mixed signals from the market. JPMorgan threw a bit of cold water on things with a pessimistic forecast for the stock. They maintained a buy rating but lowered their price target to $65. People are a bit torn because they see potential long-term, but short-term, there’s some caution creeping in. It’s like when you’re deciding whether to binge a new show or stick with your comfort series; there’s promise, but you’re not entirely sure.

    On the horizon, keep an eye out for their upcoming earnings report. That’s gonna be a big deal, and folks are really curious to see how they’ll perform. Will they blow past expectations or fall flat? We’ll just have to wait and see.

    So, to wrap it up, VKTX had a decent day but is facing some mixed feelings from analysts. Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • VKTX Today - Aug 11: Price Target Cut

    VKTX Today - Aug 11: Price Target Cut
    2026/08/11
    Hey there! It’s Joey, your friendly neighborhood investor here to break down what went down with Viking Therapeutics today. So, VKTX had a bit of a rough ride, finishing the day in the red, down about three-quarters of a percent.

    Now, here’s the scoop. The stock got hit mainly because JPMorgan decided to lower its price target for Viking from $75 to $65. Yeah, that one stung a bit. When big banks change their outlook, it can really shake things up. Investors don’t love hearing that kind of news, so you know they were quick to hit that sell button. The volume was pretty normal, nothing crazy there, just the usual trading vibe.

    But why did JPMorgan lower the target? Well, it seems like there’s some lingering uncertainty about Viking’s long-term prospects, even though some folks think the company’s future is still bright. The articles I checked out mentioned that Viking had a rough July, which might’ve influenced JPMorgan’s decision. So, it’s like this weird mix of skepticism and hope.

    On the horizon, Viking’s got some serious potential with its pipeline. They’re working on treatments for rare diseases, and that stuff can really pay off if they hit the jackpot. Investors are keeping an eye on that, for sure.

    To wrap it all up, VKTX had a tough day, mostly due to that price target cut from JPMorgan. But hey, it’s a wild market out there, and Viking’s still got some exciting things cooking. Just remember, I’m here for info and fun, not to give financial advice. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません